RBC Capital Reiterates Outperform on GoodRx Holdings, Maintains $10 Price Target
Portfolio Pulse from Benzinga Newsdesk
RBC Capital analyst Sean Dodge has reiterated an Outperform rating on GoodRx Holdings (NASDAQ:GDRX) and maintained a $10 price target.
August 16, 2024 | 3:10 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
RBC Capital analyst Sean Dodge has reiterated an Outperform rating on GoodRx Holdings and maintained a $10 price target.
The reiteration of an Outperform rating and the maintenance of a $10 price target by RBC Capital is a positive signal for investors, suggesting confidence in GoodRx Holdings' future performance. This could lead to a short-term increase in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100